ストックスクリーナーアプリを入手
9.04
8.92%
0.74
アフターアワーズ：
8.90
-0.14
-1.55%
前日終値:
$8.30
開ける：
$8.29
24時間の取引高:
5.24M
Relative Volume:
2.15
時価総額：
$1.44B
収益：
$93.95M
当期純損益:
$-129.87M
株価収益率:
-10.04
EPS:
-0.9
ネットキャッシュフロー:
$-202.88M
1週間 パフォーマンス:
+26.79%
1か月 パフォーマンス:
+23.50%
6か月 パフォーマンス:
+17.10%
1年 パフォーマンス:
-34.06%
1日の値動き範囲:
$8.175
$9.09
1週間の範囲:
$7.16
$9.75
52週間の値動き範囲:
$5.28
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
WVE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
9.04 | 1.32B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-20 | 開始されました | Wells Fargo | Overweight |
| 2025-08-04 | 開始されました | Canaccord Genuity | Buy |
| 2025-07-28 | 開始されました | Oppenheimer | Outperform |
| 2025-07-16 | 開始されました | Citigroup | Buy |
| 2025-06-11 | 再開されました | Raymond James | Outperform |
| 2025-04-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 開始されました | Wedbush | Outperform |
| 2025-02-25 | 開始されました | Jefferies | Buy |
| 2024-10-16 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | 再開されました | JP Morgan | Overweight |
| 2024-09-19 | 開始されました | B. Riley Securities | Buy |
| 2024-09-09 | 開始されました | JP Morgan | Overweight |
| 2024-05-15 | 開始されました | Wells Fargo | Overweight |
| 2023-12-19 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | 開始されました | Raymond James | Outperform |
| 2023-05-24 | ダウングレード | Jefferies | Buy → Hold |
| 2020-12-15 | 再開されました | H.C. Wainwright | Buy |
| 2020-10-23 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | 開始されました | Guggenheim | Buy |
| 2019-07-15 | 開始されました | Cowen | Market Perform |
| 2019-04-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-08-07 | 開始されました | Stifel | Buy |
| 2018-07-23 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-19 | 繰り返されました | Mizuho | Buy |
| 2017-02-15 | 開始されました | H.C. Wainwright | Buy |
| 2016-11-10 | 再開されました | Leerink Partners | Outperform |
| 2015-12-07 | 開始されました | JMP Securities | Mkt Outperform |
| 2015-12-07 | 開始されました | Jefferies | Buy |
| 2015-12-07 | 開始されました | Leerink Partners | Outperform |
| 2015-12-07 | 開始されました | Sun Trust Rbsn Humphrey | Buy |
すべてを表示
Wave Life Sciences Ltd (WVE) 最新ニュース
Is Wave Life Sciences Ltd. stock entering bullish territoryJuly 2025 Drop Watch & Free Community Supported Trade Ideas - newser.com
Can Wave Life Sciences Ltd. (1U5) stock sustain revenue momentum2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com
Wave Life Sciences Reports Breakthrough in Obesity Treatment - StocksToTrade
Published on: 2025-11-02 11:38:54 - newser.com
Why Wave Life Sciences Ltd. stock is favored by pension fundsPortfolio Update Summary & Weekly High Return Forecasts - newser.com
What insider trading reveals about Wave Life Sciences Ltd. stockWall Street Watch & Low Risk High Reward Ideas - newser.com
Heatmap analysis for Wave Life Sciences Ltd. and competitors2025 Winners & Losers & High Accuracy Trade Alerts - newser.com
Candlestick signals on Wave Life Sciences Ltd. stock today2025 Biggest Moves & Real-Time Sentiment Analysis - newser.com
Wave Life Sciences Hits Day High with 8.83% Surge in Stock Price - Markets Mojo
Wave Life Sciences Ltd. (NASDAQ:WVE) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected - simplywall.st
Can Wave Life Sciences Ltd. stock deliver sustainable ROEWeekly Trade Recap & Verified Swing Trading Watchlists - newser.com
Wave, Ibio activin E action in obesity early but solid - BioWorld MedTech
Can Wave Life Sciences Ltd. recover in the next quarter2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Is Wave Life Sciences Ltd. stock positioned for digital transformationTrade Exit Report & Real-Time Volume Spike Alerts - newser.com
Visual analytics tools that track Wave Life Sciences Ltd. performanceWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com
Can Wave Life Sciences Ltd. (1U5) stock expand revenue streamsJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
Wave Life Sciences’ obesity siRNA shows “once or twice-yearly” potential - Clinical Trials Arena
Will Wave Life Sciences Ltd. (1U5) stock top growth indexes2025 Analyst Calls & High Return Stock Watch Alerts - newser.com
WAVE Life Sciences (NASDAQ:WVE) Sees Large Volume IncreaseHere's Why - MarketBeat
Emerald Advisers LLC Has $21.17 Million Holdings in WAVE Life Sciences Ltd. $WVE - MarketBeat
A Fresh Look at Wave Life Sciences (WVE) Valuation After Recent Share Price Rally - simplywall.st
Wave Life Sciences’ WVE-007 Study: A New Frontier in Obesity Treatment - MSN
WVE files amended 8-K; corrected Exhibit 99.1, Research Day recap - Stock Titan
Wave Life Sciences (WVE) Soars 8.8%: Is Further Upside Left in the Stock? - Nasdaq
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day - GlobeNewswire
Wave Life Sciences (NASDAQ: WVE) posts 85% Activin E drop, 6‑mo durable in INLIGHT - Stock Titan
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day - GlobeNewswire Inc.
Wave Life Sciences Ltd. (WVE) Spotlight on RNA Editing and RNAi: Pipeline and Clinical Advances in Oligonucleotide TherapeuticsSlideshow (NASDAQ:WVE) 2025-10-29 - Seeking Alpha
Wave Life Sciences Reports Positive INLIGHT Trial Results - TipRanks
Wave Life Sciences Ltd Announces Positive Data from INLIGHT Clinical Trial - TradingView
WVE highlights positive target engagement for WVE-007 at Research Day - Stock Titan
Wave Life Sciences Reports Significant Activin E Reductions from WVE-007 in INLIGHT Clinical Trial, Advancing RNA Medicines Pipeline - Quiver Quantitative
Wave Life Sciences (NASDAQ: WVE) INLIGHT shows 85% Activin E drop, 6-month durability - Stock Titan
Wave Life Sciences (WVE) Shows Promise in Weight Loss Treatment Study - GuruFocus
Wave Life Sciences stock soars after promising clinical data By Investing.com - Investing.com Philippines
Wave Life Sciences stock soars after promising clinical data - Investing.com
CapEx per share of Wave Life Sciences Ltd. – MUN:1U5 - TradingView
Net current asset value per share of Wave Life Sciences Ltd. – MUN:1U5 - TradingView
Wave Life Sciences Builds RNA Momentum Ahead Of Key 2025 Data Readouts - RTTNews
Wave Life Sciences Ltd (WVE) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):